drugset / Trial / NCT00956956
A Multiple Dose Study To Determine Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Healthy Adult Subjects
RandomizedParallel-groupDouble-blindBasic science
Summary
The goals of this study are to evaluate the safety and tolerability of multiple ascending doses of PF-04455242 administered orally to healthy adult subjects. In addition, the plasma and urine pharmacokinetics of multiple ascending doses of PF 04455242 administered orally to healthy adult subjects will be evaluated. Finally, the effect of multiple-doses of PF-04455242 on serum prolactin concentration will be explored.
Timeline
- Start
- 2009-09
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04455242 | Small molecule | 3 mg | Oral |
| Subject | PF-04455242 | Small molecule | 6 mg | Oral |
| Subject | PF-04455242 | Small molecule | 23 mg | Oral |
Indications
No indication recorded.